Cargando...

Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story

This review provides an update on the current state of pharmacogenetic research in the treatment of Alzheimer's disease (AD) and Lewy body disease (LBD) as it pertains to the use of cholinesterase inhibitors (ChEI). AD and LBD are first reviewed from clinical and pathophysiological perspectives...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lam, Benjamin, Hollingdrake, Elizabeth, Kennedy, James L, Black, Sandra E, Masellis, Mario
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2009
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3525201/
https://ncbi.nlm.nih.gov/pubmed/20038497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-7364-4-2-91
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!